NewsBenzingaGlaukos宣布其评估iDose TR联合白内障手术治疗开角型青光眼或高眼压患者的4期临床试验获得顶线结果;研究达到主要疗效终点,显示出统计学显著优越性及具有临床意义的眼压降低,优于单独白内障手术 Glaukos宣布其评估iDose TR联合白内障手术治疗开角型青光眼或高眼压患者的4期临床试验获得顶线结果;研究达到主要疗效终点,显示出统计学显著优越性及具有临床意义的眼压降低,优于单独白内障手术 Benzinga 2026.10.09 11:06 (GMT+0) Open on Benzinga Other news Peter Schiff Says AI Could Rewrite the Rules of Starting a Business: ‘Don’t Look for a Job’ Hunterbrook Report: Digital Realty’s $3 Billion Georgia Data Center Hits Toxic Roadblock After White Phosphorus Found At Former Army Dump Pre-market US stocks: Memory sector broadly higher, Micron Technology (MU.O) up 2.40% AbbVie’s Dual-Target Drug Shows Phase 2 Results for Hard-to-Treat Crohn’s Disease Musk announces he will gift one SpaceX share to every child in the U.S. next year JPMorgan Extends JPM Coin to Ethereum for Institutional Clients
Hunterbrook Report: Digital Realty’s $3 Billion Georgia Data Center Hits Toxic Roadblock After White Phosphorus Found At Former Army Dump